13 results on '"Bajwa, O"'
Search Results
2. Leflunomide-Induced Interstitial Pneumonitis: A Rare Occurrence in a Case Without Underlying Lung Disease
- Author
-
Villgran, V.D., primary, Nasrullah, A., additional, and Bajwa, O., additional
- Published
- 2020
- Full Text
- View/download PDF
3. Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
- Author
-
Luca, Richeldi, du Bois, Roland M., Ganesh, Raghu, Arata, Azuma, Brown, Kevin K., Ulrich, Costabel, Vincent, Cottin, Flaherty, Kevin R., Hansell, David M., Yoshikazu, Inoue, Dong Soon Kim, Martin, Kolb, Nicholson, Andrew G., Noble, Paul W., Moisés, Selman, Hiroyuki, Taniguchi, Michèle, Brun, Florence Le Maulf, Mannaïg, Girard, Susanne, Stowasser, Rozsa Schlenker Herceg, Bernd, Disse, Collard, Harold R., Corte, T, Davies, H, Glaspole, I, Mulder, J, Veitch, E, De Vuyst, P, Liistro, G, Sibille, Y, Vincken, W, Wuyts, W, Fell, C, Hernandez, P, Kolb, M, Undurraga, A, Bai, C, Chen, P, Gao, Z, Kang, J, Li, H, Li, Z, Wan, H, Wang, H, Wen, F, Xiao, Q, Xu, Z, Zhang, W, Zheng, X, Zhu, H, Pauk, N, Reiterer, P, Vasakova, M, Hodgson, U, Bourdin, A, Cadranel, J, Camus, P, Chanez, P, Cottin, V, Crestani, B, Israel Biet, D, Jouneau, S, Lebargy, F, Marquette, C, Prévot, G, Valeyre, D, Wallaert, B, Bonnet, R, Costabel, U, Gläser, S, Grohé, C, Guenther, A, Hammerl, P, Höffken, G, Karagiannidis, C, Kirschner, J, Kirsten, A, Korn, S, Kreuter, M, Müller Quernheim, J, Neurohr, C, Pfeifer, M, Schönfeld, N, Wiewrodt, R, Antoniou, K, Daniil, Z, Diamantea, F, Koulouris, N, Mathioudakis, G, Ghosal, A, Kadappa Shivappa, S, Kawedia, M, Khatavkar, P, Kumar, A, Mehta, P, Singh, V, Srikanth, K, Thakker, H, Udwadia, Z, Egan, J, Fink, G, Kramer, M, Yigla, M, Agostini, Carlo, De Benedetto, F, Harari, S, Luppi, F, Paggiaro, P, Tavanti, L, Pesci, A, Poletti, V, Rottoli, P, Saltini, C, Sanduzzi Zamparelli, A, Vancheri, C, Bando, M, Hasegawa, Y, Hashimoto, K, Homma, S, Inase, N, Inoue, Y, Arai, T, Izumi, S, Kawamura, T, Kishi, K, Kondo, Y, Kuwano, K, Miura, Y, Nishioka, Y, Nishiyama, O, Ogura, T, Ohkouchi, S, Saito, T, Setoguchi, Y, Shindoh, J, Taguchi, Y, Tanakadate, M, Tomii, K, Sugita, Y, Yamaguchi, T, Yoshimori, K, Jeong, S, Kim, D, Kim, Y, Park, C, Song, J, Uh, S, Selman, M, Bresser, P, Grutters, J, Wijsenbeek, M, Arrobas, A, Cardoso, J, Costa, R, Morais, A, Neves, S, Serrado, M, Ilkovick, M, Vizel, A, Alfageme Michavila, I, Ancochea, J, Castillo Villegas, D, Molina Molina, M, Morell, F, Xaubet, A, Aktogu Ozkan, S, Kayacan, O, Ongen, G, Mogulkoc, N, Tuncay, E, Beirne, P, Bettinson, H, Burge, P, Dempsey, O, Maher, T, Millar, A, Spencer, L, Thickett, D, Alvarez, J, Andrews, C, Bajwa, O, Baker, A, Baughman, R, Belperio, J, Bradley, J, Collard, H, Cordova, F, Daniels, C, de Andrade, J, Dushay, K, Enelow, R, Ettinger, N, Gibson, K, Gotfried, M, Hajari Case, A, Hotchkin, D, Huggins, J, Kaye, M, Kershaw, C, Kureishy, S, Lancaster, L, Lederer, D, Mageto, Y, Masson, J, Meyer, K, Mohabir, P, Morrison, L, Nathan, S, Noth, I, Oelberg, D, Rahaghi, F, Riley, D, Rizzo, A, Rossman, M, Ruzi, J, Sachs, P, Schaumberg, T, Scholand, M, Schroeder, C, Seifer, F, Shea, J, Sinkowitz, D, Tabak, J, Taylor, J, Thompson, J, Thurm, C, Tita, J, Wencel, M, Westerman, J, Lasky, J, Demedts, M, Casteels, M, Loddenkemper, R, Michaelis, J, Roman, J, Tino, G, Luisetti, M., and Clinical sciences
- Subjects
Male ,medicine.medical_specialty ,Vital capacity ,Indoles ,Exacerbation ,Aged ,Disease Progression ,Double-Blind Method ,Enzyme Inhibitors ,Female ,Humans ,Idiopathic Pulmonary Fibrosis ,Middle Aged ,Protein Kinase Inhibitors ,Protein-Tyrosine Kinases ,Quality of Life ,Treatment Outcome ,Vital Capacity ,Settore MED/10 - Malattie dell'Apparato Respiratorio ,Medizin ,Placebo ,Gastroenterology ,FEV1/FVC ratio ,Idiopathic pulmonary fibrosis ,chemistry.chemical_compound ,Internal medicine ,medicine ,business.industry ,Medicine (all) ,Hazard ratio ,General Medicine ,Pirfenidone ,medicine.disease ,Surgery ,chemistry ,Nintedanib ,business ,medicine.drug - Abstract
Background Nintedanib (formerly known as BIBF 1120) is an intracellular inhibitor that targets multiple tyrosine kinases. A phase 2 trial suggested that treatment with 150 mg of nintedanib twice daily reduced lung-function decline and acute exacerbations in patients with idiopathic pulmonary fibrosis. Methods We conducted two replicate 52-week, randomized, double-blind, phase 3 trials (INPULSIS-1 and INPULSIS-2) to evaluate the efficacy and safety of 150 mg of nintedanib twice daily as compared with placebo in patients with idiopathic pulmonary fibrosis. The primary end point was the annual rate of decline in forced vital capacity (FVC). Key secondary end points were the time to the first acute exacerbation and the change from baseline in the total score on the St. George’s Respiratory Questionnaire, both assessed over a 52-week period. Results A total of 1066 patients were randomly assigned in a 3:2 ratio to receive nintedanib or placebo. The adjusted annual rate of change in FVC was −114.7 ml with nintedanib versus −239.9 ml with placebo (difference, 125.3 ml; 95% confidence interval [CI], 77.7 to 172.8; P
- Published
- 2014
4. Leflunomide-induced interstitial pneumonitis: A rare occurrence in a case without underlying lung disease.
- Author
-
Villgran, V.D., Rabold, E., Nasrullah, A., Disilvio, B., and Bajwa, O.
- Abstract
Pneumonitis from leflunomide is uncommon due to leflunomide's relatively favorable drug profile. Leflunomide-induced pneumonitis (LEIP) is a rare condition reported mainly in Asia. We present a case of LEIP from an accidental leflunomide overdose in the setting of concomitant methotrexate use and no underlying lung disease. Our patient was treated successfully with cholestyramine and steroids. Due to its high mortality, clinicians should be aware of this condition and its treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
5. Hypertension in Women and Pregnancy.
- Author
-
Shah A, Kapcin K, Deicke M, Pappan N, Holden K, Routray SK, Schmetzer A, DuMont T, Nashar K, Bajwa O, and Ivanova V
- Subjects
- Pregnancy, Female, Humans, Hypertension, Pre-Eclampsia diagnosis, Pre-Eclampsia epidemiology, Pre-Eclampsia therapy, Hypertension, Pregnancy-Induced diagnosis, Hypertension, Pregnancy-Induced epidemiology, Hypertension, Pregnancy-Induced therapy
- Abstract
Hypertension has been shown to have long-term cardiovascular effects if left untreated. Hypertension also has been shown to affect women during pregnancy, which can be detrimental not only to the patient but also to the fetus. Early identification and treatment are paramount to prevent adverse outcomes. This article details the epidemiology, clinical presentation, diagnosis, and treatment of essential hypertension in women, gestational hypertension, preeclampsia, and eclampsia., (Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
6. False Elevation of Troponin in a Case of Multiple Myeloma.
- Author
-
Bajwa O, Hassen G, Fishbein J, Uchenna U, and Ammar H
- Abstract
Falsely elevated troponin has been reported in the literature. The authors present a case of a 51-year-old man who was admitted with nausea, vomiting, and chest discomfort. He was found to have elevated troponin with no electrocardiographic changes. He has normal coronaries on angiogram and normal echocardiogram. A diagnostic time-out and second look at the laboratory values captured abnormalities that triggered a workup that ruled in a multiple myeloma diagnosis. We suspected falsely elevated troponin levels secondary to macrotroponin, a complex of elevated immunoglobulin levels and troponin, which has been rarely reported to cause elevated troponin levels in patients with multiple myeloma., Competing Interests: The authors have declared that no competing interests exist., (Copyright © 2023, Bajwa et al.)
- Published
- 2023
- Full Text
- View/download PDF
7. Nontraumatic Neurosurgical Emergencies.
- Author
-
Ashraf O, Bajwa O, Leonardo J, and Altenbaugh M
- Subjects
- Humans, Emergencies, Neurosurgical Procedures
- Abstract
Most neurosurgical emergencies involve management of intracranial pressure, decompression of brain parenchyma, or diversion of cerebrospinal fluid. These interventions aim to prevent progression and reverse damage to neural structures. The pathologies that require emergent treatment either develop acutely or may progress over days until they reach a critical point causing decompensation. The risk of any intervention need to be weighed against potential benefits and should involve discussions with the family. Interventions have shown to be effective and facilitate patients' return to improved functionality. However, while neurosurgical interventions are lifesaving, surviving patients may have a severe residual disability. This article presents an overview of commonly seen nontraumatic neurosurgical emergencies. Each section presents key facets of presentation, initial workup, management, and role of surgical intervention., Competing Interests: The authors have no conflicts of interest to declare., (Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
8. Amalgam phase-out, an environmental safety concern: a cross-sectional study among general dental practitioners in Pakistan.
- Author
-
Khan S, Khalid N, Bajwa O, Qamar T, Kazmi A, and Tariq A
- Subjects
- Cross-Sectional Studies, Dental Amalgam adverse effects, Humans, Pakistan, Surveys and Questionnaires, Dentists, Professional Role
- Abstract
Background: Amalgam has been the gold standard for restorations in posterior teeth. Mercury, a major component of dental amalgam, is considered an environmental pollutant. The Minamata Convention on mercury recomends a reduction in the use of mercury-containing products. Since Pakistan is a signatory to the Convention, the same amalgam phase-out limitations are implemented in Pakistan., Aims: To identify and assess the use of amalgam and its waste management by dentists in Pakistan post-Minamata Convention guidelines., Methods: A cross-sectional study was conducted in Lahore among 520 general dental practitioners in 2019., Results: The sample size for the study was calculated as 500; the questionnaire was distributed among 550 dentists. Dental amalgam was used by only 41.6% of the dentists in their practice; 55.0% perceived it to be a health risk. Most of the dentists (76.3%) were unaware of the proper disposal protocols for dental amalgam and 76.5% were unaware of any guidelines regarding amalgam use and disposal., Conclusion: Although there is a gap in knowledge among the dentists regarding amalgam disposal, dentists in Pakistan are reducing their use of dental amalgam in accordance with the guidelines of the Minamata Convention., (Copyright © World Health Organization (WHO) 2022. Open Access. Some rights reserved. This work is available under the CC BY-NC-SA 3.0 IGO license (https://creativecommons.org/licenses/by-nc-sa/3.0/igo).)
- Published
- 2022
- Full Text
- View/download PDF
9. The Role of Palliative Care in COPD.
- Author
-
Baltaji S, Cheronis N, Bajwa O, and Cheema T
- Subjects
- Anxiety, Dyspnea, Humans, Quality of Life, Palliative Care, Pulmonary Disease, Chronic Obstructive, Terminal Care
- Abstract
Chronic obstructive pulmonary disease is a highly symptomatic disease that may lead to significant morbidity. Even with optimal therapy, the patient's quality of life can be severely affected. These symptoms include dyspnea, anxiety, depression, and malnourishment. Palliative care is a branch of medicine that specializes in the care of patients with a terminal illness no matter what stage of the disease they are in. It implements a family-centered approach to help patients deal with their symptoms. It also helps with shared decision-making and advanced care planning.
- Published
- 2021
- Full Text
- View/download PDF
10. Extracorporeal Membrane Oxygenation in ARDS.
- Author
-
Naddour M, Kalani M, Ashraf O, Patel K, Bajwa O, and Cheema T
- Subjects
- Adult, History, 19th Century, History, 20th Century, History, 21st Century, Humans, Middle Aged, Extracorporeal Membrane Oxygenation history, Guidelines as Topic standards, Respiratory Distress Syndrome therapy
- Abstract
Extracorporeal membrane oxygenation (ECMO) has become a key tool in the management of cardiac and/or respiratory failure refractory to conventional management. Although ECMO has multiple indications, it has been widely studied for the management of acute respiratory distress syndrome in adults. ECMO provides rest and support while the damaged lungs heal. It is an invasive modality with risks of serious complications; therefore, clinicians should be vigilant during patient selection. Furthermore, users should be familiar with different components of the ECMO machinery and the management of different organ systems while patients are on the circuit. ECMO is a relatively new modality that has shown good results when used in certain circumstance, and its use is becoming more popular across the United States.
- Published
- 2019
- Full Text
- View/download PDF
11. Special Circumstances and Populations.
- Author
-
Singh A, Foster M, Chapman P, Hattab Y, Alhassan S, and Bajwa O
- Subjects
- Athletes, Female, Humans, Neoplasms physiopathology, Pregnancy, Pregnancy Complications, Cardiovascular epidemiology, Prevalence, Pulmonary Embolism, Risk Factors, Venous Thrombosis, Anticoagulants, Venous Thromboembolism diagnosis, Venous Thromboembolism drug therapy
- Abstract
Venous thromboembolism is a condition that includes both deep venous thrombosis and pulmonary embolism. Venous thromboembolism disease can result because of a combination of risk factors, including patient-related, treatment-related, and, more specifically, cancer-related factors. It is not disease-specific or a population-specific disorder, but it is more prevalent in certain specialty populations. This article will cover those specialty populations including cancer, pregnancy, and athletes.
- Published
- 2017
- Full Text
- View/download PDF
12. Prognosis and Monitoring of VTE.
- Author
-
Naddour M, Kalani M, Hattab Y, Gandhi V, Singh AC, and Bajwa O
- Subjects
- Anticoagulants therapeutic use, Humans, Prognosis, Pulmonary Embolism drug therapy, Recurrence, Risk Factors, Vena Cava Filters statistics & numerical data, Venous Thromboembolism drug therapy, Venous Thromboembolism mortality, Comorbidity, Pulmonary Embolism diagnosis, Venous Thromboembolism epidemiology
- Abstract
Venous thromboembolism (VTE) can present in a variety of different clinical settings and in a diverse, comorbid patient population, both of which will guide the clinician toward the appropriate therapeutic response. Patients who present with pulmonary embolism are at risk for hemodynamic instability, recurrence of VTE, cardiac comorbidities, and increased risk of overall mortality. Prognostication models have been clinically validated for risk stratification and prediction of mortality. Similar to pulmonary embolism, patients with deep vein thrombosis carry a higher risk of VTE recurrence and cardiac comorbidities. Consequently, VTE can be treated by a variety of methods such as anticoagulants or inferior vena cava filters, which bear their own risks and benefits. It is imperative that clinicians monitor patients for complications from VTE and the chosen therapy.
- Published
- 2017
- Full Text
- View/download PDF
13. Asthma.
- Author
-
Alhassan S, Hattab Y, Bajwa O, Bihler E, and Singh AC
- Subjects
- Asthma etiology, Chronic Disease, Critical Care, Disease Management, Humans, Anti-Asthmatic Agents therapeutic use, Asthma diagnosis, Asthma drug therapy
- Abstract
Asthma is one of the most frequent chronic respiratory diseases worldwide, with an increase in its prevalence in the last decade. Ongoing studies continue to search for better diagnostic tools and advanced treatment options in an effort to decrease the morbidity and mortality associated with it. Unfortunately, many asthmatic patients still suffer from poorly controlled asthma, which may lead to life-threatening situations. This article reviews the basics of asthma and highlights the current guidelines in making accurate diagnosis and initiating therapeutic plan.
- Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.